Mirum Pharmaceuticals' LIVMARLI Data Showcased at ESPGHAN Annual Meeting | Region
FOSTER CITY, Calif.--(BUSINESS WIRE)--May 18, 2024--
Source: eagletribune.com
Significant Reductions News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Significant Reductions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Significant Reductions Today - Breaking & Trending Today
Mirum Pharmaceuticals' LIVMARLI Data Showcased at ESPGHAN Annual Meeting
- Seven abstracts highlighting ALGS and PFIC data, including three oral presentations - Long-term extension data from Phase 3 MARCH-ON PFIC study presented at plenary session and selected among the...
Source: marketscreener.com
Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints
CBL-514 is the first product to treat cellulite at the raised areas. Currently, there is no effective and safe cellulite treatment on the market. The global...
Source: prnewswire.com
Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints
CBL-514 is the first product to treat cellulite at the raised areas.Currently, there is no effective and safe cellulite treatment on the market. The global market for cellulite treatment is estimated to expand to $7.37 billion in 2034.CBL-0201EFP...
Source: lelezard.com
Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints
NEW TAIPEI CITY, April 26, 2024 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) today announced the topline results of the CBL-0201EFP Phase 2 study,
Source: thailand-business-news.com